Sinil Pharmaceutical Co., Ltd.

KOSDAQ:A012790 주식 보고서

시가총액: ₩81.6b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Sinil Pharmaceutical 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Mi-Keun Jung

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권0.9%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Recent updates

Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials Driving The Negative Sentiment?

Mar 11
Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials Driving The Negative Sentiment?

Is Sinil Pharmaceutical's (KOSDAQ:012790) 122% Share Price Increase Well Justified?

Feb 13
Is Sinil Pharmaceutical's (KOSDAQ:012790) 122% Share Price Increase Well Justified?

Could The Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790) Ownership Structure Tell Us Something Useful?

Jan 17
Could The Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790) Ownership Structure Tell Us Something Useful?

Sinil Pharmaceutical's (KOSDAQ:012790) Earnings Are Growing But Is There More To The Story?

Dec 22
Sinil Pharmaceutical's (KOSDAQ:012790) Earnings Are Growing But Is There More To The Story?

Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Nov 26
Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

CEO

Mi-Keun Jung (70 yo)

no data

테뉴어

Mr. Mi-Geun Jung serves as the Chief Executive Officer and President at Shinil Pharmaceutical Co., Ltd. Mr. Jung served as a Vice President and Factory Manager of Shinil Pharmaceutical Co., Ltd. He served...